Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature

Autor: Heregger, R., Huemer, F., Hutarew, G., Hecht, S., Cheveresan, L., Kotzot, D., Schamschula, E., Rinnerthaler, G., Melchardt, T., Weiss, L., Greil, R.

Publikováno v: In ESMO Open August 2021 6(4)

Comment on: Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma

Autor: Huemer, F., Weiss, L., Regitnig, P., Winder, T., Schmitt, C.A., Thaler, J., Wöll, E., Greil, R.

Publikováno v: In ESMO Open April 2024 9(4)

530P Real-world effectiveness and predictive biomarker analysis of TAS-102+bevacizumab vs. regorafenib vs. TAS-102 in metastatic colorectal cancer: A multicenter cohort study.

Autor: Seeber, A.¹ (AUTHOR), Huemer, F.² (AUTHOR), Doleschal, B.³ (AUTHOR), Taghizadeh, H.⁴ (AUTHOR), Reimann, P.⁵ (AUTHOR), Moik, F.⁶ (AUTHOR), Kostmann, S.⁶ (AUTHOR), Wagner, L.⁶ (AUTHOR), Granitzer, J.⁷ (AUTHOR), Hamid, M. Abdel⁸ (AUTHOR), Bachleitner, C.⁹ (AUTHOR), Amann, A.¹ (AUTHOR), Wolf, D.¹⁰ (AUTHOR), Greil, R.¹¹ (AUTHOR), Jost, P.J.¹² (AUTHOR), Winder, T.⁵ (AUTHOR), Rumpold, H.¹³ (AUTHOR), Weiss, L.¹⁴ (AUTHOR), Gerger, A.⁶ (AUTHOR), Riedl, J.M.⁶ (AUTHOR)

Publikováno v: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS445-S446. 2p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.